Summary:
COMPANY:​
Gilead Sciences
INDUSTRIES:​
Biopharma, Biotechnology, Commercial, Health Care, Manufacturing, Pharmaceutical
HEADQUARTERS:​
Foster City, California, United States
ABOUT:
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
STOCK SYMBOL:
GILD: BIT – Italian Stock Exchange
IPO STATUS:
Public
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, they seek to improve the care of patients suffering from life-threatening diseases. Gilead’s primary areas of focus include HIV/AIDS, liver disease, and serious cardiovascular and respiratory conditions. Gilead Sciences was founded in 1987 and headquartered in Foster City, California.
Financials:
FUNDING (USD):​
STATUS:
For Profit
INVESTORS:​
TOP 5 INVESTORS:​
FOUNDERS:​
Michael L. Riordan
LAST LEADERSHIP HIRE:
EMPLOYEES:
10001+
ACQUISITIONS​:

Twitter:

Tokyo Office:

Gran Tokyo South Tower, 16th Floor
1-9-2 Marunouchi, Chiyoda-ku
Tokyo, 100-6616